{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibbh3d7cxjzt4q7igu5hbvhd2zxfep4nabbvf6gq2icx2amghttlm",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mjfxwrzwku22"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidyx63d3tjbesom3k2f2vdjdgwkwl2fa4ostaxsfq5kj4iioes3n4"
    },
    "mimeType": "image/jpeg",
    "size": 71788
  },
  "path": "/pharmalot/2026/04/13/fda-nudges-drugmakers-report-missing-clinical-trial-data/?utm_campaign=rss",
  "publishedAt": "2026-04-13T22:51:29.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharmalot",
    "biotechnology",
    "Clinical trials",
    "FDA",
    "Pharmaceuticals",
    "Policy",
    "public health",
    "STAT+",
    "transparency"
  ],
  "textContent": "FDA officials said an internal analysis found results were not submitted for nearly 30% of studies “highly likely” to fall under mandatory reporting requirements.",
  "title": "STAT+: FDA pushes drugmakers to report missing clinical trial results",
  "updatedAt": "2026-04-13T22:51:33.000Z"
}